Cell & Gene Therapy

For decades, animal models have served as the foundation of biomedical research and drug development. However, growing ethical concerns, high costs, and limited Read more...

Advances in human-relevant disease models have reshaped early-stage drug discovery, but the development of cell therapies demands even more sophisticated platforms Read more...

  In this recorded interview, Erik Vaessen, Chief Business Officer – Life Sciences, presents our latest innovation, Oceo Rover - the first and only Read more...

As MSCs become more popular in regenerative medicines and cell therapies, the ability to automate the manufacturing of MSC-based therapies efficiently is paramount Read more...

Achieving high cell densities in long-term cultures is often a challenge facing bioprocessing manufacturers, and one that requires the support of optimal media. Read more...

  Our careful selection of raw materials and processes help to reduce risk Regulatory agencies, including the Federal Drug Administration (FDA), the European Read more...

  An Interview with R&D Scientist Catherine Nguyen on Benefit of Using a Media Survey Panel versus Media Screen Protocols We recently sat down with Read more...

Q: What does Express Media mean and what makes it express? A: Express Media Service (EMS) refers to our service program manufacturing and delivering small-scale, Read more...

Driving the Successful Development and Production of Combination Biotherapies A presentation by Robert Newman, PhD, CSO, FUJIFILM Irvine Scientific At the 2021 Read more...

Interview with Tom Fletcher, R&D Director, Process Development, FUJIFILM Irvine Scientific Bioprocessing manufacturers face many challenges along the path Read more...